Tirzepatide is a dual-action peptide being widely studied for its activity on both GLP-1 and GIP receptors. This dual agonist profile has made it a key compound of interest in research focused on metabolic function, glucose regulation, and weight-related pathways. Known by brand names Mounjaro and Zepbound.
By targeting multiple hormone receptors involved in insulin sensitivity and appetite signaling, Tirzepatide is explored in controlled environments for its potential effects on energy balance and metabolic efficiency. Its dual-pathway mechanism offers a distinct approach compared to single-receptor compounds.
Product Details:
Compound: Tirzepatide
Format: Designed for use with a preloaded, easy-to-use delivery system
Application: Research use only
Key Features:
Easy to use, hassle-free, preloaded and ready to use
